Last Updated: 18/06/2024
Development of a novel drug class for the treatment of Plasmodium falciparum malaria
Objectives
This project aims to develop recently identified class of compounds as drug leads that fits the criteria for the treatment of Plasmodium falciparum malaria.
Principal Institution
Principal Investigators / Focal Persons
Rationale and Abstract
Recent gains made in malarial control are now threatened by the emergence of antimalarial drug resistance, which is causing up to 50% treatment failure. New drugs are needed that have novel mechanisms of action, are fast acting and show activity against all known resistant parasite strains.
External reference
Date
Jan 2020 — Dec 2022
Total Project Funding
$309,961
Funding Details
National Health and Medical Research Council (NHMRC) Australia, Australia
Grant ID: 1171794
AUD 445,920
Country / Project Site(s)
Related Resources
